Vu; Phong H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vu; Phong H..The latest application filed is for "substituted amines for treating cardiac diseases".

Company Profile

4.15.15

Vu; Phong H. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted amines for treating cardiac diseases Grant 11,197,858 - Matsunaga , et al. December 14, 2	2021-12-14
Substituted Amines For Treating Cardiac Diseases App 20200230137 - MATSUNAGA; Nobuyuki ; et al.	2020-07-23
Substituted amines for treating cardiac diseases Grant 10,543,212 - Matsunaga , et al. Ja	2020-01-28
Pyridinyl And Fused Pyridinyl Triazolone Derivatives App 20190224190 - Lawson; John David ; et al.	2019-07-25
Pyridinyl and fused pyridinyl triazolone derivatives Grant 10,307,414 - Lawson , et al.	2019-06-04
Heterocyclic Compound App 20180280389 - MATSUNAGA; Nobuyuki ; et al.	2018-10-04
Heteroarylamide inhibitors of TBK1 Grant 9,994,547 - Bigi , et al. June 12, 2	2018-06-12
Pyridinyl And Fused Pyridinyl Triazolone Derivatives App 20180015083 - Lawson; John David ; et al.	2018-01-18
Heteroarylamide Inhibitors Of Tbk1 App 20170313675 - Bigi; Simone ; et al.	2017-11-02
Pyridinyl and fused pyridinyl triazolone derivatives Grant 9,801,872 - Lawson , et al. October 31, 2	2017-10-31
Pyridinyl And Fused Pyridinyl Triazolone Derivatives App 20160310483 - Lawson; John David ; et al.	2016-10-27
Pyridinyl and fused pyridinyl triazolone derivatives Grant 9,402,841 - Lawson , et al. August 2, 2	2016-08-02
Pyridinyl And Fused Pyridinyl Triazolone Derivatives App 20140256734 - Lawson; John David ; et al.	2014-09-11
Poly (ADP-ribose) polymerase (PARP) inhibitors Grant 8,669,249 - Brown , et al. March 11, 2	2014-03-11
Poly (adp-ribose) Polymerase (parp) Inhibitors App 20120094992 - Brown; Jason W. ; et al.	2012-04-19
Histone deacetylase inhibitors Grant 7,642,253 - Bressi , et al. January 5, 2	2010-01-05
Histone deacetylase inhibitors Grant 7,642,275 - Bressi , et al. January 5, 2	2010-01-05
Histone deacetylase inhibitors Grant 7,399,884 - Bressi , et al. July 15, 2	2008-07-15
Histone deacetylase inhibitors Grant 7,381,825 - Bressi , et al. June 3, 2	2008-06-03
Histone deacetylase inhibitors Grant 7,375,228 - Bressi , et al. May 20, 2	2008-05-20
Histone Deacetylase Inhibitors App 20070173527 - Bressi; Jerome C. ; et al.	2007-07-26
Histone Deacetylase Inhibitors App 20070149495 - Bressi; Jerome C. ; et al.	2007-06-28
Histone deacetylase inhibitors Grant 7,169,801 - Bressi , et al. January 30, 2	2007-01-30
Histone deacetylase inhibitors Grant 7,154,002 - Bressi , et al. December 26, 2	2006-12-26
Histone Deacetylase Inhibitors App 20060258694 - Bressi; Jerome C. ; et al.	2006-11-16
Histone deacetylase inhibitors App 20060205941 - Bressi; Jerome C. ; et al.	2006-09-14
Histone deacetylase inhibitors App 20050137232 - Bressi, Jerome C. ; et al.	2005-06-23
Histone deacetylase inhibitors App 20040266769 - Bressi, Jerome C. ; et al.	2004-12-30
Histone deacetylase inhibitors App 20040254220 - Bressi, Jerome C. ; et al.	2004-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.